116 related articles for article (PubMed ID: 35506565)
1. Impaired reciprocal regulation between SIRT6 and TGF-β signaling in fatty liver.
Xiang X; Ohshiro K; Zaidi S; Yang X; Bhowmick K; Vegesna AK; Bernstein D; Crawford JM; Mishra B; Latham PS; Gough NR; Rao S; Mishra L
FASEB J; 2022 Jun; 36(6):e22335. PubMed ID: 35506565
[TBL] [Abstract][Full Text] [Related]
2. Analysis of Genomes and Transcriptomes of Hepatocellular Carcinomas Identifies Mutations and Gene Expression Changes in the Transforming Growth Factor-β Pathway.
Chen J; Zaidi S; Rao S; Chen JS; Phan L; Farci P; Su X; Shetty K; White J; Zamboni F; Wu X; Rashid A; Pattabiraman N; Mazumder R; Horvath A; Wu RC; Li S; Xiao C; Deng CX; Wheeler DA; Mishra B; Akbani R; Mishra L
Gastroenterology; 2018 Jan; 154(1):195-210. PubMed ID: 28918914
[TBL] [Abstract][Full Text] [Related]
3. Sirtuin 6 deficiency transcriptionally up-regulates TGF-β signaling and induces fibrosis in mice.
Maity S; Muhamed J; Sarikhani M; Kumar S; Ahamed F; Spurthi KM; Ravi V; Jain A; Khan D; Arathi BP; Desingu PA; Sundaresan NR
J Biol Chem; 2020 Jan; 295(2):415-434. PubMed ID: 31744885
[TBL] [Abstract][Full Text] [Related]
4. SIRT6 controls hepatic lipogenesis by suppressing LXR, ChREBP, and SREBP1.
Zhu C; Huang M; Kim HG; Chowdhury K; Gao J; Liu S; Wan J; Wei L; Dong XC
Biochim Biophys Acta Mol Basis Dis; 2021 Dec; 1867(12):166249. PubMed ID: 34425214
[TBL] [Abstract][Full Text] [Related]
5. SIRT6 Protects Against Liver Fibrosis by Deacetylation and Suppression of SMAD3 in Hepatic Stellate Cells.
Zhong X; Huang M; Kim HG; Zhang Y; Chowdhury K; Cai W; Saxena R; Schwabe RF; Liangpunsakul S; Dong XC
Cell Mol Gastroenterol Hepatol; 2020; 10(2):341-364. PubMed ID: 32305562
[TBL] [Abstract][Full Text] [Related]
6. SPTBN1 inhibits inflammatory responses and hepatocarcinogenesis via the stabilization of SOCS1 and downregulation of p65 in hepatocellular carcinoma.
Lin L; Chen S; Wang H; Gao B; Kallakury B; Bhuvaneshwar K; Cahn K; Gusev Y; Wang X; Wu Y; Marshall JL; Zhi X; He AR
Theranostics; 2021; 11(9):4232-4250. PubMed ID: 33754058
[No Abstract] [Full Text] [Related]
7. Sirtuin 6 promotes transforming growth factor-β1/H2O2/HOCl-mediated enhancement of hepatocellular carcinoma cell tumorigenicity by suppressing cellular senescence.
Feng XX; Luo J; Liu M; Yan W; Zhou ZZ; Xia YJ; Tu W; Li PY; Feng ZH; Tian DA
Cancer Sci; 2015 May; 106(5):559-66. PubMed ID: 25683165
[TBL] [Abstract][Full Text] [Related]
8. Loss of cooperative function of transforming growth factor-beta signaling proteins, smad3 with embryonic liver fodrin, a beta-spectrin, in primary biliary cirrhosis.
Mishra B; Tang Y; Katuri V; Fleury T; Said AH; Rashid A; Jogunoori W; Mishra L
Liver Int; 2004 Dec; 24(6):637-45. PubMed ID: 15566516
[TBL] [Abstract][Full Text] [Related]
9. βII-Spectrin (SPTBN1) suppresses progression of hepatocellular carcinoma and Wnt signaling by regulation of Wnt inhibitor kallistatin.
Zhi X; Lin L; Yang S; Bhuvaneshwar K; Wang H; Gusev Y; Lee MH; Kallakury B; Shivapurkar N; Cahn K; Tian X; Marshall JL; Byers SW; He AR
Hepatology; 2015 Feb; 61(2):598-612. PubMed ID: 25307947
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional regulation of STAT3 by SPTBN1 and SMAD3 in HCC through cAMP-response element-binding proteins ATF3 and CREB2.
Lin L; Yao Z; Bhuvaneshwar K; Gusev Y; Kallakury B; Yang S; Shetty K; He AR
Carcinogenesis; 2014 Nov; 35(11):2393-403. PubMed ID: 25096061
[TBL] [Abstract][Full Text] [Related]
11. Reciprocal Regulation between SIRT6 and miR-122 Controls Liver Metabolism and Predicts Hepatocarcinoma Prognosis.
Elhanati S; Ben-Hamo R; Kanfi Y; Varvak A; Glazz R; Lerrer B; Efroni S; Cohen HY
Cell Rep; 2016 Jan; 14(2):234-42. PubMed ID: 26748705
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor beta signaling in hepatocytes participates in steatohepatitis through regulation of cell death and lipid metabolism in mice.
Yang L; Roh YS; Song J; Zhang B; Liu C; Loomba R; Seki E
Hepatology; 2014 Feb; 59(2):483-95. PubMed ID: 23996730
[TBL] [Abstract][Full Text] [Related]
13. Sirtuin 6 inhibits myofibroblast differentiation via inactivating transforming growth factor-β1/Smad2 and nuclear factor-κB signaling pathways in human fetal lung fibroblasts.
Zhang Q; Tu W; Tian K; Han L; Wang Q; Chen P; Zhou X
J Cell Biochem; 2019 Jan; 120(1):93-104. PubMed ID: 30230565
[TBL] [Abstract][Full Text] [Related]
14. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW
Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833
[TBL] [Abstract][Full Text] [Related]
15. The deacetylase sirtuin 6 protects against kidney fibrosis by epigenetically blocking β-catenin target gene expression.
Cai J; Liu Z; Huang X; Shu S; Hu X; Zheng M; Tang C; Liu Y; Chen G; Sun L; Liu H; Liu F; Cheng J; Dong Z
Kidney Int; 2020 Jan; 97(1):106-118. PubMed ID: 31787254
[TBL] [Abstract][Full Text] [Related]
16. β2-spectrin (SPTBN1) as a therapeutic target for diet-induced liver disease and preventing cancer development.
Rao S; Yang X; Ohshiro K; Zaidi S; Wang Z; Shetty K; Xiang X; Hassan MI; Mohammad T; Latham PS; Nguyen BN; Wong L; Yu H; Al-Abed Y; Mishra B; Vacca M; Guenigault G; Allison MED; Vidal-Puig A; Benhammou JN; Alvarez M; Pajukanta P; Pisegna JR; Mishra L
Sci Transl Med; 2021 Dec; 13(624):eabk2267. PubMed ID: 34910547
[TBL] [Abstract][Full Text] [Related]
17. Linker phosphorylation of Smad3 promotes fibro-carcinogenesis in chronic viral hepatitis of hepatocellular carcinoma.
Murata M; Yoshida K; Yamaguchi T; Matsuzaki K
World J Gastroenterol; 2014 Nov; 20(41):15018-27. PubMed ID: 25386050
[TBL] [Abstract][Full Text] [Related]
18. Sirtuin6 (SIRT6) Promotes the EMT of Hepatocellular Carcinoma by Stimulating Autophagic Degradation of E-Cadherin.
Han LL; Jia L; Wu F; Huang C
Mol Cancer Res; 2019 Nov; 17(11):2267-2280. PubMed ID: 31551254
[TBL] [Abstract][Full Text] [Related]
19. TGF-β signaling is often attenuated during hepatotumorigenesis, but is retained for the malignancy of hepatocellular carcinoma cells.
Mu X; Lin S; Yang J; Chen C; Chen Y; Herzig MC; Washburn K; Halff GA; Walter CA; Sun B; Sun LZ
PLoS One; 2013; 8(5):e63436. PubMed ID: 23704908
[TBL] [Abstract][Full Text] [Related]
20. Sirt6 suppresses hepatocellular carcinoma cell growth via inhibiting the extracellular signal‑regulated kinase signaling pathway.
Zhang ZG; Qin CY
Mol Med Rep; 2014 Mar; 9(3):882-8. PubMed ID: 24366394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]